Search results: “PD-1”

Accelerate COVID-19 drug discovery & development programs targeting proinflammatory cytokines & others with qualified assays

Ready-to-use kits for biologics characterization, MOA confirmation, NAbs detection, stability studies, & potency testing

Accelerate cancer immunotherapy drug development with easy-to-use, functional cell-based assays targeted at checkpoint receptors

Simple, non-radioactive, & dye-free cytotoxicity assays to specifically measure target cell death

Ready-to-use, cell-based bioassay kits to measure direct cell death for screening, characterization, & potency testing

Accelerate cancer immunotherapeutic discovery & development with cell-based, clinically relevant assays

Simple, orthogonal reporter-based assays for screening & understanding therapeutic MOAs